Clinical outcomes of reperfusion therapy in patients with site-specific basilar artery occlusion

医学 溶栓 改良兰金量表 病因学 闭塞 置信区间 冲程(发动机) 大脑中动脉 外科 内科学 回顾性队列研究 优势比 心脏病学 缺血 缺血性中风 心肌梗塞 工程类 机械工程
作者
Nina Žakelj,Igor Rigler,Alja Longo,Senta Frol,Janja Pretnar Oblak
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:17 (11): 1249-1253 被引量:3
标识
DOI:10.1136/jnis-2024-022065
摘要

Background Despite its low incidence, basilar artery occlusion (BAO) remains a major therapeutic challenge since severe disability and death occur in about 80% of patients. Specific site of BAO (proximal, middle, or distal) has rarely been reported as a prognostic factor in reperfusion therapy. We aimed to explore the relationship between site-specific BAO and clinical outcomes in patients treated with reperfusion therapies. Methods We performed a single-centre retrospective study of all consecutive patients with acute BAO admitted to the University Medical Centre Ljubljana between January 2013 and August 2022 who were treated with reperfusion therapies. Patients were grouped according to the location of BAO and compared for baseline characteristics, differences in stroke aetiology, type of reperfusion therapy, success of recanalization, and clinical outcome after 90 days evaluated by the modified Rankin Scale (mRS) score. Statistical analysis was performed with the two-sided ANOVA t-tests for continuous measures, Chi-squared (χ2) tests for categorical measures and a multivariate ordinal logistic regression analysis. Results The study included 103 patients (47% females, median age 74 years; confidence interval (CI) 72 to 98). Proximal BAO was found in 13%, middle in 13%, and distal in 74% of patients. Cardioembolic etiology was more common in distal (=0.01), and atherosclerotic etiology in proximal and middle BAO occlusions (P=0.02). While distal BAO was more likely to be recanalized using intravenous thrombolysis (IVT) compared with other sites of occlusion (P=0.05), we found no difference between different occlusion sites and the success of endovascular treatment (EVT). Lower age (odds ratio (OR) 0.89; CI 0.84 to 0.95; P<0.01) and shorter time to intervention (OR 0.71; CI 0.53 to 0.95; P=0.02), regardless of it being IVT or EVT, were predictors of an excellent clinical outcome (mRS 0–2). Distal occlusion (OR 28; CI 2.7 to 300; p<0.01) was a strong predictor of a favorable clinical outcome (mRS 0–3). Conclusion Prompt reperfusion, regardless of it being IVT or EVT, increases the chance of excellent clinical outcomes in patients with acute BAO. Distal BAO is more often associated with a favorable clinical outcome compared with the proximal and middle segments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
惕守应助江峰采纳,获得10
2秒前
高玉峰发布了新的文献求助10
3秒前
leslie应助tang采纳,获得10
3秒前
科目三应助LOVOTE采纳,获得10
4秒前
米酒发布了新的文献求助10
5秒前
科研通AI6应助伊影采纳,获得30
5秒前
5秒前
汉堡包应助Liii采纳,获得10
5秒前
5秒前
ycc完成签到,获得积分10
5秒前
CC发布了新的文献求助10
5秒前
6秒前
6秒前
Chengsir完成签到,获得积分10
7秒前
小高同学完成签到,获得积分10
7秒前
sunialnd应助cenghao采纳,获得110
8秒前
ZhangH完成签到,获得积分10
8秒前
研友_VZG7GZ应助科研通管家采纳,获得10
8秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
BowieHuang应助科研通管家采纳,获得10
8秒前
6666应助科研通管家采纳,获得10
8秒前
Ava应助科研通管家采纳,获得10
9秒前
充电宝应助科研通管家采纳,获得10
9秒前
斯文败类应助高高断秋采纳,获得10
9秒前
英俊的铭应助科研通管家采纳,获得10
9秒前
852应助科研通管家采纳,获得10
9秒前
科研通AI6应助科研通管家采纳,获得30
9秒前
风清扬应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
嘿嘿应助科研通管家采纳,获得20
9秒前
9秒前
9秒前
丘比特应助科研通管家采纳,获得10
9秒前
田様应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
11完成签到,获得积分20
9秒前
传奇3应助清新的南琴采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
King Tyrant 720
Sport, Social Media, and Digital Technology: Sociological Approaches 650
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5594225
求助须知:如何正确求助?哪些是违规求助? 4679892
关于积分的说明 14811940
捐赠科研通 4646251
什么是DOI,文献DOI怎么找? 2534795
邀请新用户注册赠送积分活动 1502789
关于科研通互助平台的介绍 1469475